News
Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical ...
East Midlands-based biotechnology company N4 Pharma has formed a new senior leadership team featuring consultants in drug ...
Strive Asset Management has raised $750 million to pursue the strategy while Ramaswamy runs to be Ohio’s governor.
Big Biotech Biogen is venturing into the city, paying $16 million in cash to partner up with an RNAi company to build ...
As the World Health Organization initiates a new agreement for coordinating global responses to future pandemics, the future ...
I n her State of the City address in March, Mayor Michelle Wu spoke about her then-2-month-old daughter. The world she ...
VectorY Therapeutics, a biotechnology company developing innovative vectorized antibody therapies for the treatment of ...
As venture funding becomes concentrated in fewer, larger rounds, a biotech with operations in Newton has secured a ...
It’s GlycoEra’s time to shine. The biotech has closed a series B fundraise clocking in at $130 million, with the funds set to ...
Job cuts at home-grown pharma companies like Arvinas and RallyBio and federal policies challenge CT biotech 'ecosystem' that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results